FDA Inspection 1208022 — Parker Laboratories, Inc.

Parker Laboratories, Inc. — FEI 2212018

The FDA completed an inspection of Parker Laboratories, Inc. on Jun 14, 2023 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 14, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fairfield, NJ (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
191421 CFR 211.166(a)Lack of written stability program
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
437321 CFR 211.188(b)(7)Actual yield, % of theoretical yield
439121 CFR 211.180(e)(2)Items to cover on annual reviews

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.